ET
BIO icon

Entropy Technologies’s Bio-Rad Laboratories Class A BIO Stock Holding History

Entropy Technologies’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,400
Closed -$1.06M – 825
2025
Q2 		$1.06M Buy
4,400
+3,200
+267% +$756K 0.08% 292
2025
Q1 		$292K Sell
1,200
-967
-45% -$291K 0.03% 544
2024
Q4 		$712K Sell
2,167
-2,033
-48% -$690K 0.07% 359
2024
Q3 		$1.41M Buy
+4,200
New +$1.33M 0.15% 206
2024
Q2 		– Sell
-3,845
Closed -$1.33M – 680
2024
Q1 		$1.33M Sell
3,845
-2,096
-35% -$689K 0.14% 219
2023
Q4 		$1.92M Buy
+5,941
New +$1.86M 0.36% 76

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Entropy Technologies's BIO Position: Q3 2025 in Review

Entropy Technologies sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2025, closing a stake of 4,400 shares — an estimated $1.06M sold.

Entropy Technologies first reported a position in BIO in Q4 2023 and held it in 6 quarters. The position peaked at $1.92M in Q4 2023. 396 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

  • Entropy Technologies reported no remaining Bio-Rad Laboratories Class A position as of Q3 2025 after selling out during the quarter.
  • Entropy Technologies sold 4,400 Bio-Rad Laboratories Class A shares in Q3 2025, an estimated $1.06M.
  • Entropy Technologies first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and held it in 6 quarters.
  • Entropy Technologies's Bio-Rad Laboratories Class A position peaked at $1.92M in Q4 2023.
  • 396 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on Entropy Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.